Delivery Order SPE2DB24D1021-SPE2DB25FFASL
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of QSYMIA 15 mg-92 mg capsules (30-count units) with a firm fixed price ceiling value of $1,643.28. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,810.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count), a prescription weight management medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for $1,225.31 on June 5, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules (30-count package). This is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing...
- The Defense Logistics Agency awarded a $1,547.92 delivery order to AmerisourceBergen Drug Corp for QSYMIA 7.5 MG-46 MG capsules (30-count units), a pharmaceutical product used in weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $1,642.44 worth of Qsymia 11.25mg-69mg tablets (30-count) under a firm fixed-price contract. The award was made competitively without set-aside restrictions and is scheduled for completion by September 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. This delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract, which has a potential value of $4,014.36, has a completion date of February 21, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order and will deliver the product to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Qsymia 15mg-92mg in 30-count packages, with a ceiling value of $2,738.80. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is performable in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025, and represents a child delivery order under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Qsymia 15 mg-92 mg capsules (30-count units) with a ceiling value of $1,732.83. This firm fixed-price delivery order, with an ultimate completion date of May 14, 2025, represents a pediatric or standard-dose pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries...